These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14154337)

  • 41. [The importance of CSF enzymes in clinical practice (author's transl)].
    Rodriguez Navarro I; Nieto Vales JM; Casto del Pozo S; Ortiz Manchado O
    Munch Med Wochenschr; 1973 Dec; 115(51):2293-9. PubMed ID: 4603891
    [No Abstract]   [Full Text] [Related]  

  • 42. The protective effect of normal and pathological (Wilson disease) ceruloplasmins on human erythrocytes.
    Saenko EL; Skorobogat'ko OV; Yaropolov AI
    Biochem Int; 1990; 20(3):463-9. PubMed ID: 2161227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
    Atsuba Y; Nakahachi T; Terai T; Kozakai T
    No To Shinkei; 1968 Feb; 20(2):187-95. PubMed ID: 5695072
    [No Abstract]   [Full Text] [Related]  

  • 44. Production of melanins by ceruloplasmin.
    Rosei MA; Foppoli C; Wang XT; Coccia R; Mateescu MA
    Pigment Cell Res; 1998 Apr; 11(2):98-102. PubMed ID: 9585247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. THE QUESTION OF COPPER DEFICIENCY IN MAN.
    Cartwright GE; Wintrobe MM
    Am J Clin Nutr; 1964 Aug; 15(2):94-110. PubMed ID: 14225916
    [No Abstract]   [Full Text] [Related]  

  • 46. A kinetic method amenable to automation for ceruloplasmin estimation with inexpensive and stable reagents.
    Somani BL; Ambade V
    Clin Biochem; 2007 May; 40(8):571-4. PubMed ID: 17367772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zinc, copper and ceruloplasmin in arteriosclerosis.
    Bustamante JB; Mateo MC; Fernandez J; de Quiros B; Manchado OO
    Biomedicine; 1976 Sep; 25(7):244-5. PubMed ID: 990382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical polymorphism and ceruloplasmin variants in hepatolenticular degeneration].
    Vakharlovskiĭ VG; Moshkov KA; Shavlovskiĭ MM; Neĭfakh SA
    Genetika; 1977; 13(7):1294-1304. PubMed ID: 21123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychiatric aspects of Wilson disease: a review.
    Zimbrean PC; Schilsky ML
    Gen Hosp Psychiatry; 2014; 36(1):53-62. PubMed ID: 24120023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low ceruloplasmin in a patient with Niemann-Pick type C disease.
    Connemann BJ; Gahr M; Schmid M; Runz H; Freudenmann RW
    J Clin Neurosci; 2012 Apr; 19(4):620-1. PubMed ID: 22269206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [THE LATENT PERIOD OF CORTICAL (SPONTANEOUS) MOTOR ACTIVITY IN PATIENTS WITH VASCULAR DISEASES OF THE BRAIN AND MULTIPLE SCLEROSIS (ACCORDING TO ELECTROPHYSIOLOGICAL DATA)].
    MARKOV DA; KOSHKINA NI; LEONOVICH AL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():659-63. PubMed ID: 14065773
    [No Abstract]   [Full Text] [Related]  

  • 53. CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN WILSON'S DISEASE IN CASES UNDER TEN YEARS OF AGE.
    ARIMA M; KOMIYA K; KAMOSHITA S; MUKAI N
    Paediatr Univ Tokyo; 1963 Dec; 9():17-22. PubMed ID: 14157269
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pathogenesis of cerebral disorders in hepatocerebral dystrophy].
    Lekar' PG; Makarova VA; Botvinnik VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):346-50. PubMed ID: 2883792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failure of copper incorporation into ceruloplasmin in the Golgi apparatus of LEC rat hepatocytes.
    Murata Y; Yamakawa E; Iizuka T; Kodama H; Abe T; Seki Y; Kodama M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):349-55. PubMed ID: 7726856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical aspects of hepatolenticular degeneration. Study of the "turnover" of copper in some extrapyramidal syndromes].
    Agnoli A; Casacchia M; Fieschi C
    Recenti Prog Med; 1970 Oct; 49(4):385-98. PubMed ID: 5537615
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the need of ceruloplasmin and serum copper analyses in the diagnosis of Wilson's disease].
    Nomoto S; Kanai M; Matsuda Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):190. PubMed ID: 4475792
    [No Abstract]   [Full Text] [Related]  

  • 58. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
    Wolf TL; Kotun J; Meador-Woodruff JH
    Schizophr Res; 2006 Sep; 86(1-3):167-71. PubMed ID: 16842975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
    RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
    Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of neurologic and psychiatric diseases on pregnancy, delivery, and puerperium].
    Sievers S; Grumbrecht C
    Geburtshilfe Frauenheilkd; 1972 Oct; 32(10):835-9. PubMed ID: 4652278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.